{
  "documentId": "case-study-202206-150237",
  "title": "External Appeal Case Study: 202206-150237",
  "slug": "external-appeal-case-202206-150237",
  "excerpt": "New York DFS external appeal decision for ADHD coverage - case 202206-150237",
  "content": [
    {
      "__component": "shared.paragraph",
      "content": "This case represents an external appeal decision rendered by the New York Department of Financial Services (DFS) regarding coverage for ADHD treatment. The decision demonstrates the regulatory framework supporting evidence-based ADHD treatment when supported by comprehensive clinical documentation and established medical necessity standards."
    },
    {
      "__component": "shared.heading",
      "content": "Case Overview",
      "level": 2
    },
    {
      "__component": "shared.paragraph",
      "content": "Case Number: 202206-150237\n\nDecision Summary: External appeal granted for ADHD medication based on medical necessity standards and clinical evidence"
    },
    {
      "__component": "shared.heading",
      "content": "Medical Evidence Presented",
      "level": 2
    },
    {
      "__component": "shared.paragraph",
      "content": "Medications Attempted: FDA-approved ADHD medication with comprehensive monitoring\n\nCondition Treated: ADHD - Attention Deficit Hyperactivity Disorder"
    },
    {
      "__component": "shared.heading",
      "content": "Reviewer Decision Rationale",
      "level": 2
    },
    {
      "__component": "shared.paragraph",
      "content": "Medical necessity established through comprehensive clinical evaluation, functional impairment assessment, and appropriate treatment monitoring. The documentation supported the clinical rationale for medication choice and dosing protocols, demonstrating adherence to established medical guidelines and regulatory requirements for evidence-based ADHD care."
    },
    {
      "__component": "shared.heading",
      "content": "Evidence-Based Treatment Standards",
      "level": 2
    },
    {
      "__component": "shared.paragraph",
      "content": "This case highlights the importance of evidence-based treatment protocols in establishing medical necessity for ADHD medications. The comprehensive documentation included standardized diagnostic evaluation, systematic functional impairment assessment, appropriate treatment trial protocols, and ongoing monitoring with documented clinical response and safety evaluations."
    },
    {
      "__component": "shared.heading",
      "content": "Regulatory Oversight Impact",
      "level": 2
    },
    {
      "__component": "shared.paragraph",
      "content": "The external appeal review process applied rigorous standards to ensure coverage determinations align with established medical practice and regulatory requirements. This decision demonstrates the regulatory commitment to evidence-based coverage decisions that prioritize patient care and clinical outcomes over arbitrary limitations."
    },
    {
      "__component": "shared.heading",
      "content": "Healthcare Provider Best Practices",
      "level": 2
    },
    {
      "__component": "shared.paragraph",
      "content": "Healthcare providers should reference this case when developing comprehensive documentation for ADHD treatment coverage requests. The decision reinforces the importance of systematic evaluation, evidence-based treatment selection, ongoing monitoring, and detailed clinical rationale supporting medical necessity determinations for ADHD medications."
    },
    {
      "__component": "shared.heading",
      "content": "Precedent Value for Future Cases",
      "level": 2
    },
    {
      "__component": "shared.paragraph",
      "content": "This decision establishes important precedent for similar cases, demonstrating that comprehensive clinical documentation and evidence-based treatment protocols significantly improve external appeal success rates. The regulatory framework prioritizes medical necessity over arbitrary coverage limitations when supported by appropriate clinical evidence and systematic monitoring."
    }
  ],
  "publishedAt": "2025-10-28T16:41:38.000Z",
  "createdAt": "2025-10-28T16:41:38.000Z",
  "updatedAt": "2025-10-28T16:41:38.000Z",
  "seo": {
    "metaTitle": "Case Study 202206-150237 - External Appeal Decision | ADHD Clearinghouse",
    "metaDescription": "New York DFS external appeal case study for ADHD coverage - case 202206-150237",
    "keywords": ["external appeal", "NY DFS", "case study", "adhd", "insurance coverage"]
  },
  "categories": [
    {
      "documentId": "category-legal-precedents",
      "name": "Legal Precedents",
      "slug": "legal-precedents"
    }
  ],
  "tags": [
    {
      "documentId": "tag-external-appeals",
      "name": "External Appeals",
      "slug": "external-appeals"
    },
    {
      "documentId": "tag-ny-dfs",
      "name": "NY DFS",
      "slug": "ny-dfs"
    },
    {
      "documentId": "tag-case-studies",
      "name": "Case Studies",
      "slug": "case-studies"
    },
    {
      "documentId": "tag-insurance-coverage",
      "name": "Insurance Coverage",
      "slug": "insurance-coverage"
    }
  ]
}